Luanlin Zhiluo Hedian Jiaonang (卵磷脂络合碘胶囊)卵磷脂络合碘胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司
主要成分Active Ingredients
- 卵磷脂络合碘Luanlin Zhiluo Hedian
药物知识说明
卵磷脂络合碘是一种在国家药监局注册认定的药品。标注生产企业为西安汉丰药业有限责任公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司、西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司、西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 卵磷脂络合碘胶囊) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 西安汉丰药业有限责任公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司, 西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司, 西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 卵磷脂络合碘胶囊Recorded Chinese name: 卵磷脂络合碘胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.1mg*30粒0.1 mg × 30 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 西安汉丰药业有限责任公司Chinese legal name: 西安汉丰药业有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20100107
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20100107
Manufacturer
Chinese legal name: 西安汉丰药业有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.1 mg × 30 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20100107
生产企业
西安汉丰药业有限责任公司(国产)
适应症
治疗中心性浆液性脉络膜视网膜病变，中心性渗出性脉络膜视网膜病变，玻璃体出血，玻璃体混浊，视网膜中央静脉阻塞等。
用法用量
口服，成人一次1-3粒，一日2-3次。
不良反应
1.过敏反应：偶发皮疹。
2.消化道反应：偶尔发生胃肠不适。
禁忌
对碘过敏者禁用。
注意事项
1.慢性甲状腺疾病患者，曾患突眼性甲状腺肿的患者，内源性甲状腺素合成不足的患者慎用。
2.由于老年人生理机能降低，应在使用时适当减量并小心监护。
3.本品对妊娠妇女或疑为妊娠的妇女，只有在治疗价值大于可能带来的风险时，方可使用。
4.须遵医嘱使用。
贮藏
密封，置阴凉处。
规格
0.1mg*30粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.